BioRestorative Therapies
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $303 | $25 | $43 | $233 |
Gross Profit | 294 | 22 | 39 | 215 |
EBITDA | -3,305 | -4,807 | -2,639 | -2,238 |
EBIT | -4,859 | -2,690 | -2,286 | |
Net Income | -2,656 | -5,339 | -1,636 | -1,091 |
Net Change In Cash | 303 | 25 | 43 | 233 |
Free Cash Flow | -2,693 | -2,778 | -2,360 | -1,758 |
Cash | 1,555 | 1,228 | 547 | 1,489 |
Basic Shares | 8,740 | 8,357 | 7,763 | 8,121 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $401 | $145 | $119 | $46 |
Gross Profit | 372 | -19 | 119 | 46 |
EBITDA | -11,366 | -10,251 | -18,853 | -26,218 |
EBIT | -11,555 | -10,417 | -18,974 | -26,423 |
Net Income | -8,979 | -10,417 | -13,222 | -44,303 |
Net Change In Cash | 401 | 145 | 119 | 46 |
Free Cash Flow | -8,336 | -6,601 | -6,310 | -3,360 |
Cash | 547 | 884 | 1,713 | 21,026 |
Basic Shares | 7,763 | 4,218 | 3,617 | 1,187 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.64 |
2024-12-31 | -$0.37 |
